Table 2 Arrhythmia, ST depression, ST elevation, T-negativity and block numbers of groups.
From: Evaluation of the cardiopulmonary effects of repurposed COVID-19 therapeutics in healthy rats
Parameters | Kategoriler | Control (n:8) | HCLQ (n:8) | FAVI (n:9) | MOL (n:9) | HCLQ + FAVI (n:9) | MOL + DEX (n:7) | HCLQ + FAVI + DEX (n:10) |
|---|---|---|---|---|---|---|---|---|
Arrhythmia | exist | 8 (100.00%) | 8 (100.00%) | 8 (88.89%) | 9 (100.00%) | 8 (88.89%) | 7 (100.00%) | 10 (100.00%) |
absent | 0 (0.00%) | 0 (0.00%) | 1 (11.11%) | 0 (0.00%) | 1 (11.11%) | 0 (0.00%) | 0 (0.00%) | |
ST depression | exist | 8 (100.00%) | 8 (100.00%) | 9 (100.00%) | 6 (66.67%) | 9 (100.00%) | 6 (85.71%) | 10 (100.00%) |
absent | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 3 (33.33%) | 0 (0.00%) | 1 (14.29%) | 0 (0.00%) | |
ST elevation | exist | 8 (100.00%) | 8 (100.00%) | 9 (100.00%) | 9 (100.00%) | 9 (100.00%) | 7 (100.00%) | 10 (100.00%) |
absent | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | |
T-negativity | exist | 8 (100.00%) | 8 (100.00%) | 8 (88.89%) | 5 (55.56%) | 8 (88.89%) | 5 (71.43%) | 7 (70.00%) |
absent | 0 (0.00%) | 0 (0.00%) | 1 (11.11%) | 4 (44.44%) | 1 (11.11%) | 2 (28.57%) | 3 (30.00%) | |
Block | exist | 8 (100.00%) | 3 (37.50%) | 2 (22.22%) | 4 (44.44%) | 2 (22.22%) | 1 (14.29%) | 5 (50.00%) |
absent | 0 (0.00%) | 5 (62.50%) | 7 (77.78%) | 5 (55.56%) | 7 (77,78%) | 6 (85,71%) | 5 (50.00%) |
